Funded Startups in Plano
Across the 45 most recent funded rounds tied to Plano, the largest disclosed amount is $600M for Aligned (2024-03-12).
Across the 45 most recent funded rounds tied to Plano, the largest disclosed amount is $600M for Aligned (2024-03-12). That figure dwarfs the next-highest disclosed rounds shown: Orano Med at $347M (2025-10-10) and Critical Start at $215M (2022-04-12), with most other disclosed amounts clustered well below $100M (for example, Centra Funding is $175M but still far under the $600M outlier).
The date window is wide (2020-12-12 through 2026-05-13), but activity is denser in the most recent stretch: multiple disclosed rounds appear from 2025-09 through 2026-04 (e.g., AmplifAI $34M on 2025-09-28; UPTIQ $25M on 2026-02-12; Starlight Therapeutics $2M on 2026-04-15). Stage and disclosure are also mixed: 18 of 45 entries list an undisclosed amount and 18 list a Series Unknown/blank stage label, indicating substantial reporting gaps alongside clearer rounds such as Series B (e.g., UPTIQ $25M on 2026-02-12; AmplifAI $34M on 2025-09-28).
Most recent rounds
45 shownRelated listings
Frequently asked
What stands out in round size, and how does the biggest disclosed amount compare to the rest of the Plano entries shown?
The largest disclosed round is Aligned’s $600M on 2024-03-12, which dwarfs the next-highest disclosed amounts in the list: Orano Med’s $347M (2025-10-10) and Critical Start’s $215M (2022-04-12). Even other large disclosed entries like Centra Funding at $175M (2026-05-13) and UPTIQ at $25M (2026-02-12) sit far below the $600M outlier.
Is there a noticeable cluster in timing within the 45 rows, especially near the top of the list?
Yes, recent rounds cluster in late 2025 through mid-2026: AmplifAI closed $34M on 2025-09-28, Orano Med $347M on 2025-10-10, and then multiple disclosed rounds follow in 2026 such as UPTIQ $25M (2026-02-12), Starlight Therapeutics $2M (2026-04-15), and Centra Funding $175M (2026-05-13).
How much of the Plano set is missing disclosed economics or stage labels, based on the rows shown?
Substantial gaps appear in both dimensions: 18 of 45 entries show an undisclosed amount (e.g., momoGood on 2026-03-11; Certainti on 2026-02-17; Fundbox on 2026-01-21), and 18 of 45 list Series Unknown/blank stage (e.g., Centra Funding is “Series Unknown” on 2026-05-13; Aligned is blank stage on 2024-03-12; Dwler is blank stage on 2020-12-12).
Which funding stages (where disclosed) show up repeatedly across these Plano entries?
Among labeled stages, Series B appears multiple times with disclosed amounts such as UPTIQ $25M (2026-02-12), Ares Materials $12M (2025-10-12), and AmplifAI $34M (2025-09-28). Seed rounds also recur (e.g., Xcaliber $7M on 2026-05-05; Starlight Therapeutics $2M on 2026-04-15; FoxEyes $540K on 2025-10-08).
Are there outliers in sector mix or disclosure level that would skew analysis of “typical” rounds?
Several entries look like analysis-breakers relative to the rest: Aligned’s $600M (2024-03-12) is an extreme size outlier, while Orano Med’s $347M (2025-10-10) and Centra Funding’s $175M (2026-05-13) are also far above the mid-range of many other disclosed rounds. In parallel, reporting gaps are common—undisclosed amounts appear across multiple sectors and stages, such as Financial Services (Fundbox on 2026-01-21) and Education (Certainti on 2026-02-17).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.